Taiwan Advanced Nanotech Inc. (TPEX:6797)

Market Cap	407.37M -22.0%
Revenue (ttm)	154.37M -21.9%
Net Income	-226.61M
EPS	-7.41
Shares Out	30.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,066
Open	13.70
Previous Close	13.70
Day's Range	13.00 - 13.70
52-Week Range	12.00 - 20.70
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Taiwan Advanced Nanotech

Taiwan Advanced Nanotech Inc. engages in the development, manufacturing, and sales of various functional nanoparticles and automated nucleic acid extraction equipment in Taiwan. The company provides automated extraction instruments; nucleic acid extraction kit that extracts DNA/RNA from samples of blood, cell, tissue, plant, bacteria, virus, etc.; consumables, such as spin tips and deep well plates; filling line systems; and molecular biology reagents. It also provides OEM/ODM services. The company was founded in 2004 and is based in Taoyuan Ci...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6797

Financial Performance

In 2025, Taiwan Advanced Nanotech's revenue was 154.37 million, a decrease of -21.87% compared to the previous year's 197.59 million. Losses were -226.61 million, 18.9% more than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error